Nu-Life Operations in Japan
Our partnership with Foxmark and collaboration Besli Clinic, specializing in neuromodulation, in Tokyo has take a leap forward, as Phase I clinical has been performed and we now move on to Phase II utilizing our new Nu-V3 5.0 device. After years of preparation for launching Nu-V3 in japan and Asia, we are now ready to showcase Nu-V3 5.0 and create awareness in Japan through the Besli Clinic and dedicated solely to neuromodulation.
05
Nu-Life launches webcast and webinar series
As an integral part of our LSX and CEO Magazine series for creating awareness and demand for Nu-V3, we are launching our first in a series of webinars dedicated to to neuroscience and the application. of neuromodulation, highlighting the benefits of our non-invasive and non-pharmaceutical approach.
06
Nu-Life CEO headlines the Investival Showcase USA
The Investival Showcase is an opportunity to speak directly to high-level, MedTech investors and strategic partners. This is a great opportunity to prepare for global expansion beginning with Japan and Europe, 2026.
07
LSX World Congress to Coincide with Nu-V3 market launch
As Nu-Life prepares to clear regulatory and after creating awareness and demand early 2026, we will again serve as Platinum Sponsor and Keynote speaker at the LSX World Congress in Europe, march, 2026.
08
From Development to Commercialization - Capitalizing Nu-V3 for market Entry
Nu-Life Solutions launches the Market Entry Offering, An opportunity to participate in the market launch of Nu-V3 globally beginning with the United States, Japan, and Europe in. 2026.
08